Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Stomach Neoplasms 1

Interventions

Fluorouracil 7 Oxaliplatin 6 Nivolumab 5 Leucovorin 5 fludarabine 4 Paclitaxel 4 Docetaxel 4 Cyclophosphamide 4 Capecitabine 4 zimberelimab 3 pembrolizumab 3 aldesleukin 3 Trastuzumab 3 Ramucirumab 3 ulixertinib 2 trastuzumab deruxtecan 2 fludarabine phosphate 2 Specimen Handling 2 Irinotecan 2 Cisplatin 2 zolbetuximab 1 zanidatamab 1 trifluridine tipiracil drug combination 1 trastuzumab biosimilar HLX02 1 trametinib 1 toripalimab 1 tislelizumab 1 sodium propionate 1 sapanisertib 1 relatlimab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Stomach Neoplasms × bemarituzumab × 30 days × Clear all

NCT05052801 2026-05-27

FORTITUDE-101

Amgen

Phase 3 Completed

Gastrointestinal

Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡